Accordingly, inhibition of the androgen receptor abolishes the increase of GLUT12 expression by everolimus, both in gastric cancer cells and a xenografted mice model, favoring the antitumoral effects of the drug, as occurs by knocking down GLUT12 [12]. The gene discussed is SLC2A12; the disease is gastric cancer.